Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Nicotine | The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Nicotine. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Mecamylamine. |
| Pentolinium | The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Trimethaphan. |
| Hexamethonium | The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Hexamethonium. |
| Cyclopentamine | The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Cyclopentamine. |
| Methotrexate | The protein binding of Methotrexate can be increased when combined with Sulfametopyrazine. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfametopyrazine. |
| Dexketoprofen | The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfametopyrazine. |
| Cyclosporine | The risk or severity of renal failure can be increased when Sulfametopyrazine is combined with Cyclosporine. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin pork. |
| Troglitazone | The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfametopyrazine. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfametopyrazine. |
| Sulfisoxazole | The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfametopyrazine. |
| Disopyramide | The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfametopyrazine. |
| Acarbose | The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfametopyrazine. |
| Metformin | The therapeutic efficacy of Metformin can be increased when used in combination with Sulfametopyrazine. |
| Sulfadiazine | The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfametopyrazine. |
| Rosiglitazone | The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfametopyrazine. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfametopyrazine. |
| Quinine | The therapeutic efficacy of Quinine can be increased when used in combination with Sulfametopyrazine. |
| Miglitol | The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfametopyrazine. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfametopyrazine. |
| Nateglinide | The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfametopyrazine. |
| Pentamidine | The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfametopyrazine. |
| Mifepristone | The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfametopyrazine. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfametopyrazine. |
| Repaglinide | The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfametopyrazine. |
| Phenformin | The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfametopyrazine. |
| Sulfamethoxazole | The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfametopyrazine. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfametopyrazine. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfametopyrazine. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfametopyrazine. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfametopyrazine. |
| Pioglitazone | The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfametopyrazine. |
| Bromocriptine | The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfametopyrazine. |
| Gliquidone | The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfametopyrazine. |
| Mitiglinide | The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfametopyrazine. |
| Sitagliptin | The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfametopyrazine. |
| Sunitinib | The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfametopyrazine. |
| Exenatide | The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfametopyrazine. |
| Mecasermin | The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfametopyrazine. |
| Pramlintide | The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfametopyrazine. |
| Glisoxepide | The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfametopyrazine. |
| Insulin aspart | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin aspart. |
| Insulin detemir | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin detemir. |
| Insulin glulisine | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin glulisine. |
| Glymidine | The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfametopyrazine. |
| AICA ribonucleotide | The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfametopyrazine. |
| Buformin | The therapeutic efficacy of Buformin can be increased when used in combination with Sulfametopyrazine. |
| Vildagliptin | The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfametopyrazine. |
| Voglibose | The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfametopyrazine. |
| NN344 | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with NN344. |
| AMG-222 | The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfametopyrazine. |
| Bisegliptin | The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfametopyrazine. |
| Alogliptin | The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfametopyrazine. |
| Dapagliflozin | The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfametopyrazine. |
| Saxagliptin | The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfametopyrazine. |
| Liraglutide | The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfametopyrazine. |
| Gosogliptin | The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfametopyrazine. |
| Linagliptin | The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfametopyrazine. |
| Canagliflozin | The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfametopyrazine. |
| Glibornuride | The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfametopyrazine. |
| Benfluorex | The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfametopyrazine. |
| Empagliflozin | The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfametopyrazine. |
| Albiglutide | The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfametopyrazine. |
| Dulaglutide | The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfametopyrazine. |
| Lobeglitazone | The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfametopyrazine. |
| Netoglitazone | The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfametopyrazine. |
| Rivoglitazone | The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfametopyrazine. |
| Ciglitazone | The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfametopyrazine. |
| Lixisenatide | The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfametopyrazine. |
| Insulin beef | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin beef. |
| Insulin degludec | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin degludec. |
| Insulin peglispro | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin peglispro. |
| Insulin tregopil | The risk or severity of hypoglycemia can be increased when Sulfametopyrazine is combined with Insulin tregopil. |
| Ipragliflozin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfametopyrazine. |
| Dutogliptin | The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfametopyrazine. |
| Allicin | The therapeutic efficacy of Allicin can be increased when used in combination with Sulfametopyrazine. |
| Tofogliflozin | The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfametopyrazine. |
| Ertugliflozin | The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfametopyrazine. |
| 2,4-thiazolidinedione | The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfametopyrazine. |
| Teneligliptin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfametopyrazine. |
| Omarigliptin | The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfametopyrazine. |
| Carmegliptin | The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfametopyrazine. |
| Gemigliptin | The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfametopyrazine. |
| Anagliptin | The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfametopyrazine. |
| Evogliptin | The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfametopyrazine. |
| Sotagliflozin | The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfametopyrazine. |
| Balaglitazone | The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfametopyrazine. |
| Remogliflozin etabonate | The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfametopyrazine. |
| Carbutamide | The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfametopyrazine. |
| Guar gum | The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfametopyrazine. |
| Metahexamide | The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfametopyrazine. |
| Semaglutide | The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfametopyrazine. |
| Taspoglutide | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfametopyrazine. |
| Englitazone | The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfametopyrazine. |